Skip to main content
Gary Phillips, MD, Endocrinology, Peekskill, NY, Montefiore St. Luke's Cornwall

GaryPhillipsMD

Endocrinology Peekskill, NY

Diabetes, Lipid Metabolism

Assistant Professor, Radiology, Georgetown University Hospital

Are you Dr. Phillips?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 80 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Gary Phillips, MD is an endocrinologist in Peekskill, New York. He is currently licensed to practice medicine in New York, Pennsylvania, and Maryland. He is affiliated with Montefiore Nyack Hospital and Montefiore St. Luke's Cornwall.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1993
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1991
  • Icahn School of Medicine at Mount Sinai (Cabrini)
    Icahn School of Medicine at Mount Sinai (Cabrini)Residency, Internal Medicine, 1986 - 1989
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Surgery, 1984 - 1986
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License Current
  • NY State Medical License
    NY State Medical License 1985 - 2025
  • PA State Medical License
    PA State Medical License 1997 - 2022
  • MD State Medical License
    MD State Medical License 1990 - 1991
  • American Board of Internal Medicine Internal Medicine

Press Mentions

  • Pharmaxis Receives Interim Data for Phase 2 Cancer Trial
    Pharmaxis Receives Interim Data for Phase 2 Cancer TrialOctober 19th, 2022
  • Pharmaxis Reports Progress in Clinical Trials Despite COVID Affecting Industry
    Pharmaxis Reports Progress in Clinical Trials Despite COVID Affecting IndustryFebruary 3rd, 2022
  • Cancer Drug Development Company Gathering Momentum as More Researchers Worldwide Take Notice
    Cancer Drug Development Company Gathering Momentum as More Researchers Worldwide Take NoticeAugust 13th, 2021
  • Join now to see all

Hospital Affiliations